Trial intelligence / Profile preview

Memantine and donepezil effects on TMS-induced motor cortex plasticity in mild cognitive impairment

2009-014810-87Phase 2Terminated

Sponsor
Servier
Start
May 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of memantine and donepezil in Mild Cognitive Impairment (MCI) (4 arms), sponsored by Servier. Started May 2011; status: terminated.

02

Drugs

memantinedonepezil
03

Conditions

Mild Cognitive Impairment (MCI)

Beyond the preview

Go deeper on 2009-014810-87.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-014810-87.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call